thigrlsrk
- Roche gets approval in Japan for Elvidys( Sarepta s GT for DMD) 3-8 yrs.
- The fucker can't mandate egg prices how's he going to do it with drugs. His kids are short pharma today you can bet on that.
- [Not loaded yet]
- Think his Kids and Buddies went short Pharma on Friday .
- 1/Latest in tariff omnishambles. This is not a deal. The US just blinked. The lesson for China: US escalation cannot be maintained. For the US: we will still see inflation and the chance of recession. For the world: the end of US credibility. www.nytimes.com/2025/05/12/b...
- OH we didn't mean it. Imbeciles running the country.
- Sarepta current MC under 4 B, 2.5 to 3 B in revenues this year, 600 million in cash. 16 to 20 B would be a normal Valuation. Analysts say Key drug in trouble -it is not. Only viable choice, approved, life saving. There is NO New safety concern.
